Interestingly, from the fourth generation in 129S2/Sv 45% of Nanos3 heterozygous males showed teratoma formation (n = 20), with 5% showing bilateral tumors (Fig. 5 A), whereas control animals (n = 17) remained tumor-free. This evidence concerns the gene NANOS3 and teratoma.